Mark Ramondt





Mark Ramondt

Co-Founder at MultiplAI

A serial (failed) entrepreneur and advisor/mentor to startups with 20+ years of experience in regional and global senior management roles in large multinationals, including more than ten as CFO and driving Open Innovation processes. Passionate about sustainability, innovation, technology, creating the future and enjoying the present with friends, family, and fine food and wine. Adaptability is the key to happiness.

MultiplAI provides a universal remote screening test for complex diseases like cancer. We use a liquid biopsy of whole blood based on RNA sequencing and AI to detect virtually any kind of cancer. It can be used in continuous testing both for preventative screening and post-treatment monitoring. Given that it requires only a simple blood sample, it can be administered remotely, anywhere, and costs a fraction of existing diagnostic methods.

The Worldwide Business School for Life Sciences

Barcelona Campus

Barcelona Scientific Park
Baldiri Reixac St., 4-8, 08028, Barcelona
info@bbibarcelona.com

Entity Associated to 

Cambridge Campus

The Bradfield Centre, Cambridge Science Park
184, Milton Road, CB4 0GA, Cambridge
info@bbicambridge.com

Entity based at 

          

Mexico Campus

World Trade Center CDMX, Montecito 38,
Col. Nápoles, 03810, Mexico City
info@bbimexico.com

Entity based at 

In educational collaboration agreement for the development of the Global MBAs

Biotechnology Business Institute ©2022 All Rights Reserved | Wolke SAS